Treatment of Relapsed or Chemotherapy Refractory Chronic Lymphocytic Leukemia or Indolent B Cell Lymphoma Using Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Thomas Jefferson University
Ohio State University Comprehensive Cancer Center
Genmab
AstraZeneca
Genmab
Hackensack Meridian Health
University Hospital, Caen
Medical University of South Carolina
Fate Therapeutics
Center for International Blood and Marrow Transplant Research
Merck Sharp & Dohme LLC
Masonic Cancer Center, University of Minnesota
University of Chicago
M.D. Anderson Cancer Center
Allogene Therapeutics
Hoffmann-La Roche
National Institutes of Health Clinical Center (CC)
Fred Hutchinson Cancer Center
Dartmouth-Hitchcock Medical Center
Dana-Farber Cancer Institute
Mayo Clinic
H. Lee Moffitt Cancer Center and Research Institute
Center for International Blood and Marrow Transplant Research
Imugene Limited
University of California, San Francisco
National Institutes of Health Clinical Center (CC)
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
French Innovative Leukemia Organisation
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
Thomas Jefferson University
Thomas Jefferson University
Dana-Farber Cancer Institute
Weill Medical College of Cornell University
City of Hope Medical Center
Sana Biotechnology
University of Maryland, Baltimore
Jonsson Comprehensive Cancer Center
Center for International Blood and Marrow Transplant Research
Roswell Park Cancer Institute
Cancer Trials Ireland
Masonic Cancer Center, University of Minnesota
Roswell Park Cancer Institute
Case Comprehensive Cancer Center
University Health Network, Toronto
Mayo Clinic
Masonic Cancer Center, University of Minnesota